Provided by Tiger Fintech (Singapore) Pte. Ltd.

Leap Therapeutics Inc

0.2616
-0.0181-6.47%
Post-market: 0.26990.0083+3.17%19:47 EDT
Volume:1.02M
Turnover:286.19K
Market Cap:10.84M
PE:-0.15
High:0.2914
Open:0.2750
Low:0.2616
Close:0.2797
Loading ...

BRIEF-Leap Therapeutics Reports Fourth Quarter And FY 2024 Results

Reuters
·
26 Mar

Leap Therapeutics Q4 Operating Expenses USD 16.125 Million

THOMSON REUTERS
·
26 Mar

Leap Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results

PR Newswire
·
26 Mar

Leap Therapeutics Reports Positive Updated Data From Sirexatamab Colorectal Cancer Study

THOMSON REUTERS
·
26 Mar

Leap Therapeutics Reports Positive Updated Data from Sirexatamab Colorectal Cancer Study

PR Newswire
·
26 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
24 Mar

Leap Therapeutics Inc expected to post a loss of 38 cents a share - Earnings Preview

Reuters
·
21 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
20 Mar

Leap Therapeutics Inc expected to post a loss of 38 cents a share - Earnings Preview

Reuters
·
14 Mar

Leap Therapeutics Shares Tumble After Downgrades from Baird, HC Wainwright

MT Newswires Live
·
30 Jan

Baird Downgrades Leap Therapeutics to Neutral From Outperform, Cuts Price Target to $1.25 From $9

MT Newswires Live
·
29 Jan

HC Wainwright Downgrades Leap Therapeutics to Neutral From Buy

MT Newswires Live
·
29 Jan

Leap Therapeutics Cut to Neutral From Buy by HC Wainwright & Co.

Dow Jones
·
29 Jan

Leap Therapeutics, Inc. : H.c. Wainwright Cuts to Neutral From Buy

THOMSON REUTERS
·
29 Jan

U.S. RESEARCH ROUNDUP-Apple, Coinbase Global, Nextracker

Reuters
·
29 Jan

Leap Therapeutics Inc : Baird Cuts to Neutral Rating; Cuts Target Price to $1.25 From $9

THOMSON REUTERS
·
29 Jan

Gold Gains 1%; Boeing Shares Rise Following Q4 Results

Benzinga
·
29 Jan

Leap Therapeutics Shares Down 62.8% After Discontinuing Late-Stage Trials of Gastric Cancer Treatment

THOMSON REUTERS
·
28 Jan

Leap Therapeutics Shares Slide After Initial Mid-Stage Cancer-Drug Results

Dow Jones
·
28 Jan

BUZZ-Leap tumbles on discontinuation of gastric cancer treatment trials

Reuters
·
28 Jan